ECT/Succinylcholine: Biochemical, Serum and Cardiovascular Changes

Stopped early

Conditions studied: Depression

In brief

This study will be conducted to determine the pharmacodynamics, cardiovascular and biochemical effects of succinylcholine when given during electroconvulsive therapy. (ECT). This is a single center, prospective, study in patients who will be receiving ECT as indicated and prescribed by their psychiatrist. The study will be performed twice on each patient, 48-72 hours apart during consecutively scheduled ECT procedures.

Key facts

Study ID

NCT00750906

Run by

University of California, San Francisco

People needed

13

Starts

2008-10-01

Expected to finish

2015-04-30

Last updated by the study team

2020-01-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A male or non-pregnant female aged 18 years and older
• American Society of Anesthesiologists physical status 1, 2, 3
• Scheduled to undergo electroconvulsive therapy under general anesthesia
• Have given written informed consent

You may not qualify if…

• Pregnant or nursing
• Any patient in the study investigators opinion who may not be suitable for research.

Where it is running

• University of California San Francisco — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.